BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15332261)

  • 1. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.
    Kobayashi H; Jo SK; Kawamoto S; Yasuda H; Hu X; Knopp MV; Brechbiel MW; Choyke PL; Star RA
    J Magn Reson Imaging; 2004 Sep; 20(3):512-8. PubMed ID: 15332261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
    Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
    Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
    Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
    Kobayashi H; Kawamoto S; Choyke PL; Sato N; Knopp MV; Star RA; Waldmann TA; Tagaya Y; Brechbiel MW
    Magn Reson Med; 2003 Oct; 50(4):758-66. PubMed ID: 14523962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
    Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
    Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
    NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart.
    Simor T; Gaszner B; Oshinski JN; Waldrop SM; Pettigrew RI; Horváth IG; Hild G; Elgavish GA
    J Magn Reson Imaging; 2005 May; 21(5):536-45. PubMed ID: 15834916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
    J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent.
    Kobayashi H; Kawamoto S; Jo SK; Sato N; Saga T; Hiraga A; Konishi J; Hu S; Togashi K; Brechbiel MW; Star RA
    Kidney Int; 2002 Jun; 61(6):1980-5. PubMed ID: 12028438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent.
    Yamamoto T; Ikuta K; Oi K; Abe K; Uwatoku T; Hyodo F; Murata M; Shigetani N; Yoshimitsu K; Shimokawa H; Utsumi H; Katayama Y
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2787-90. PubMed ID: 15125933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
    Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K
    Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-sized MRI contrast agents with dendrimer cores.
    Kobayashi H; Brechbiel MW
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2271-86. PubMed ID: 16290152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging.
    Sonoda A; Nitta N; Ohta S; Seko A; Jo J; Morikawa S; Tabata Y; Takahashi M; Murata K
    Eur J Radiol; 2009 Sep; 71(3):570-5. PubMed ID: 18502598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.